Public Profile

Jiheng Pharmaceutical

Jiheng Pharmaceutical Co., Ltd., commonly referred to as Jiheng Pharma, is a prominent player in the pharmaceutical industry, headquartered in India. Established in 2001, the company has made significant strides in the development and manufacturing of high-quality generic medications and active pharmaceutical ingredients (APIs). With a strong operational presence across Asia and expanding into global markets, Jiheng Pharma is dedicated to enhancing healthcare through innovative solutions. The company’s core offerings include a diverse range of therapeutic products, particularly in the fields of cardiovascular, anti-infective, and central nervous system treatments. Jiheng Pharma distinguishes itself through rigorous quality control and a commitment to research and development, ensuring that its products meet international standards. Recognised for its reliability and excellence, Jiheng Pharmaceutical continues to solidify its market position, contributing to improved health outcomes worldwide.

DitchCarbon Score

How does Jiheng Pharmaceutical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

0

Industry Average

Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

6

Industry Benchmark

Jiheng Pharmaceutical's score of 0 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Jiheng Pharmaceutical's reported carbon emissions

Jiheng Pharmaceutical, headquartered in India, currently does not have publicly available carbon emissions data or specific reduction targets. Without concrete figures or commitments, it is challenging to assess their climate impact or initiatives. However, the pharmaceutical industry is increasingly focusing on sustainability and reducing carbon footprints. Companies in this sector are often encouraged to adopt science-based targets and engage in climate pledges to mitigate their environmental impact. As Jiheng Pharmaceutical navigates this landscape, it may consider establishing measurable goals and reporting frameworks to enhance transparency and accountability in their climate commitments.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Jiheng Pharmaceutical's primary industry is Chemicals nec, which is medium in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Jiheng Pharmaceutical is headquartered in IN, which has a rank of very high, indicating very high grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Jiheng Pharmaceutical is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Other Organizations in Chemicals

Seitetsu Oxyton K.K.

JP
Chemicals
Updated 3 days ago

Thermotec Australia Pty Ltd

AU
Chemicals
Updated 10 days ago

Harbin Pharma

CN
Chemicals
Updated 10 days ago

Guangzhou Shangtai Chemical Co

CN
Chemicals
Updated 10 days ago

Scott Bader

GB
Chemicals
Updated 8 days ago

OSF Flavors

US
Chemicals
Updated 10 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers